Clinical Trial Update: Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intestinal inflammation in ankylosing spondylitis and how adalimumab affects mucosal healing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Regionshospitalet Silkeborg | Conditions: Spondyloarthritis, Enterocolitis | Phase 4 | Status: COMPLETED | Results posted: 2014-11-17